Evidence map›Paper›PMID 37459408›Full record

ArticleCirculation2023

Socioeconomic Disparities and Mediators for Recurrent Atherosclerotic Cardiovascular Disease Events After a First Myocardial Infarction.

Joel Ohm, Ralf Kuja-Halkola, Anna Warnqvist, Henrike Häbel, Per H Skoglund, Johan Sundström, Kristina Hambraeus, Tomas Jernberg, Per Svensson

Abstract read
In one paragraph

Article in Circulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joel OhmDepartment of Emergency Medicine Solna (J.O.), Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0001-6841-1904
Ralf Kuja-HalkolaDepartment of Medical Epidemiology and Biostatistics (R.K.-H.), Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3765-2067
Anna WarnqvistInstitute of Environmental Medicine, Division of Biostatistics (A.W., H.H.), Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-5691-2127
Henrike HäbelInstitute of Environmental Medicine, Division of Biostatistics (A.W., H.H.), Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-5564-4258
Per H SkoglundDepartment of Medicine Solna (J.O., P.H.S.), Karolinska Institutet, Stockholm, Sweden.
Johan SundströmDepartment of Medical Sciences, Uppsala University, Sweden (J.S.).ORCID 0000-0003-2247-8454
Kristina HambraeusDepartment of Cardiology, Falu Hospital, Falun, Sweden (K.H.).
Tomas JernbergDepartment of Clinical Sciences, Danderyd University Hospital (T.J.), Karolinska Institutet, Stockholm, Sweden.
Per SvenssonDepartment of Clinical Science and Education, Södersjukhuset (P.S.), Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0372-6272

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLow socioeconomic status is associated with worse secondary prevention use and prognosis after myocardial infarction (MI). Actions for health equity improvements warrant identification of risk mediators. Therefore, we assessed mediators of the association between socioeconomic status and first recurrent atherosclerotic cardiovascular disease event (rASCVD) after MI.

methodsIn this cohort study on 1-year survivors of first-ever MI with Swedish universal health coverage ages 18 to 76 years, individual-level data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) and linked national registries was collected from 2006 through 2020. Exposure was socioeconomic status by disposable income quintile (principal proxy), educational level, and marital status. The primary outcome was rASCVD and secondary outcomes were cardiovascular and all-cause mortality. We initially assessed the incremental attenuation of hazard ratios with 95% CIs in sequential multivariable models adding groups of potential mediators (ie, previous risk factors, acute presentation and infarct severity, initial therapies, and secondary prevention). Thereafter, the proportion of excess rASCVD associated with a low income mediated through nonparticipation in cardiac rehabilitation, suboptimal statin management, a cardiometabolic risk profile, persistent smoking, and blood pressure above target after MI were calculated using causal mediation analysis.

resultsAmong 68 775 participants (73.8% men), 7064 rASCVD occurred during a mean 5.7-year follow-up. Income, adjusted for age, sex, and calendar year, was associated with rASCVD (hazard ratio, 1.63 [95% CI, 1.51-1.76] in the lowest versus highest income quintile). Risk attenuated most by adjustment for previous risk factors and by adding secondary prevention variables for a final model (hazard ratio, 1.38 [95% CI, 1.26-1.51]) in the lowest versus highest income quintile. The proportions of the excess 15-year rASCVD risk in the lowest income quintile mediated through nonparticipation in cardiac rehabilitation, cardiometabolic risk profile, persistent smoking, and poor blood pressure control were 3.3% (95% CI 2.1-4.8), 3.9% (95% CI, 2.9-5.5), 15.2% (95% 9.1-25.7), and 1.0% (95% CI 0.6-1.5), respectively. Risk mediation through optimal statin management was negligible.

conclusionsNonparticipation in cardiac rehabilitation, a cardiometabolic risk profile, and persistent smoking mediate income-dependent prognosis after MI. In the absence of randomized trials, this causal inference approach may guide decisions to improve health equity.

Indexed as

AtherosclerosisCardiovascular DiseasesHydroxymethylglutaryl-CoA Reductase InhibitorsMyocardial InfarctionCohort StudiesFemaleHumansMaleRisk FactorsSocioeconomic Disparities in HealthHydroxymethylglutaryl-CoA Reductase Inhibitorscardiovascular diseaseshealth equitymediation analysissecondary preventionsocial determinants of health

Identifiers

PMID37459408
PMCPMC10348618

What OpenQuestion holds

Texttitle and abstract
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.